TY - CHAP T1 - Prostate biopsy related infection – Risk factors, prevention strategies and management approaches T2 - Urogenital Infections and Inflammations AU - Bennett, Harrison Y. AU - Harris, Patrick N. AU - Holmes, Michael AU - Grummet, Jeremy AU - Roberts, Matthew ED - Naber, Kurt G. AD - Matthew Roberts, The University of Queensland, Faculty of Medicine, Butterfield Street, 4029, Brisbane, Australien, E-mail: m.roberts2@uq.edu.au N2 - Infectious complications following prostate biopsy are reported to be increasing in incidence with associated individual and public health burden. Complication rates parallel a rise in antibiotic resistant colonisation of rectal flora in patients undergoing biopsy. Following systematic review, risk factors for post biopsy infection, preventative strategies, alternative sampling methods, and management of infectious complications are presented. Risk factors for infection should be identified; including urogenital infection or antibiotic use, international travel, hospital exposure, bacteriuria, or previous transrectal biopsy. Patients with risk factors may benefit from an adjusted biopsy protocol-comprising transrectal biopsy under targeted prophylaxis, and/or the use of rectal disinfection techniques as well as a transperineal biopsy approach. Management of post biopsy infection should be based on individual risk, local resistance profiles, and in collaboration with infectious diseases specialty physicians. PY - 2018 DA - 2018/09/19 DO - 10.5680/lhuii000040 LA - en L1 - https://books.publisso.de/de/system/getFile/147 UR - https://dx.doi.org/10.5680/lhuii000040 L2 - https://dx.doi.org/10.5680/lhuii000040 KW - prostate KW - biopsy KW - infection KW - sepsis KW - complications KW - fluoroquinolone resistance PB - German Medical Science GMS Publishing House CY - Berlin ER -